The firm will pay nearly $440 million to 33 states following a probe into its marketing.Read More
The FDA’s approach was both reasoned and consistent with the law, according to ruling. Read More
The case pertains to Altria’s 2018 investment in Juul, which has lost considerable value. Read More
This ruling effectively reverses a marketing denial order for flavored Bidi Sticks. Read More
The rule protects residents, prevents fires and reduces maintenance, says defendant.Read More
A court ruling requires the agency to take a another look at six marketing applications.Read More
The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
The verdict concerns counterclaims in RJR’s ongoing lawsuit over PMI’s IQOS device.Read More
